AUROBINDO PHARMA LTD
לונג

a very positive structure with interesting developments

the sandoz acquisition, is going to add 50% of the last fy revenue , with balance sheet leveraged to 0.7 de ratio...

disclaimer... not an investing/trading recommendation

כתב ויתור